LD-2 disclosure · 3rd Quarter - Report
MT PHARMA AMERICA, INC.
Client
- Name
- MT PHARMA AMERICA, INC.
- Description
- Pharmaceutical Company
- Location
- New Jersey · United States of America
Registrant
- Description
- Lobbying Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases. General education about federal policies impacting pharmaceutical development, approval, and reimbursement.
LobbyistsKARINA LYNCH · NICOLE MARIE RUZINSKI BERTSCH
Covered position (KARINA LYNCH): Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases. General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.
LobbyistsKARINA LYNCH · NICOLE MARIE RUZINSKI BERTSCH
Covered position (KARINA LYNCH): Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs
TargetedSENATE · HOUSE OF REPRESENTATIVES